Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (24)
Wafaa Saleh, Hamad Alharbi & Seunghee Cha. (2024) Increased prevalence of erythema multiforme in patients with COVID-19 infection or vaccination. Scientific Reports 14:1.
Crossref
Crossref
Fahime Edalat, Fatemeh Hosseini Tabatabaie, Afagh Moattari, Arash Letafati, Jamal Sarvari & Seyed Younes Hosseini. (2024) Delving into revolutionary SARS-CoV-2 vaccine approaches: Molecular and virological examinations; principles of SARS-CoV-2 vaccine platform. Vacunas 25:1, pages 109-127.
Crossref
Crossref
Wafaa Saleh, Hamad Alharbi, Sijia Yue & Rui P. Fernandes. (2023)
Lichen planus after
COVID
‐19 infection and vaccination
. Oral Diseases.
Crossref
Crossref
Anthony M Marchese, Matthew Rousculp, John Macbeth, Hadi Beyhaghi, Bruce T Seet & Seth Toback. (2023) The Novavax Heterologous Coronavirus Disease 2019 Booster Demonstrates Lower Reactogenicity Than Messenger RNA: A Targeted Review. The Journal of Infectious Diseases.
Crossref
Crossref
Valeria Graceffa. (2023) Intracellular protein delivery: New insights into the therapeutic applications and emerging technologies. Biochimie 213, pages 82-99.
Crossref
Crossref
Sulieman Ibraheem Shelash Al-Hawary, Ebraheem Abdu Musad Saleh, Nodirjon Akhmetovich Mamajanov, Nataliya S. Gilmanova, Hashem O. Alsaab, Adel Alghamdi, Shakeel Ahmed Ansari, Ahmed Hussien Radie Alawady, Ali Hashiem Alsaalamy & Ahmed Jaber Ibrahim. (2023) Breast cancer vaccines; A comprehensive and updated review. Pathology - Research and Practice 249, pages 154735.
Crossref
Crossref
Rabeya Tajnur, Refaya Rezwan, Md. Abdul Aziz & Mohammad Safiqul Islam. (2023) An update on vaccine status and the role of nanomedicine against SARS‐CoV‐2: A narrative review. Health Science Reports 6:7.
Crossref
Crossref
Tjaša Šinkovec Savšek, Mojca Zajc Avramovič, Tadej Avčin, Miša Korva, Tatjana Avšič Županc & Nataša Toplak. (2023) Disease relapse rate in children with autoimmune rheumatic diseases after COVID-19 infection and vaccination. Pediatric Rheumatology 21:1.
Crossref
Crossref
Andrew Ford, Angela Hwang, Annie X. Mo, Shahida Baqar, Nancy Touchette, Carolyn Deal, Deborah King, Kristen Earle, Birgitte Giersing, Peter Dull & B. Fenton Hall. (2023) Meeting Summary: Global Vaccine and Immunization Research Forum, 2021. Vaccine 41:11, pages 1799-1807.
Crossref
Crossref
Xuan Yi, Yuhao Wang, Quanrun Li, Xiaoyi Li, Panli Zhang, Xin Fu, Shuqin Gu, Daqian Zhang, Xiaoyi Liu, Haonan Lou, Yuemei Wu, Libo Tang, Jinlin Hou & Yongyin Li. (2023) Pre‐existing immunity to SARS‐CoV‐2 associates with strong T cell responses induced by inactivated COVID‐19 vaccines. Journal of Medical Virology 95:3.
Crossref
Crossref
Abdul Aziz Al-Fattah Yahaya, Kanwal Khalid, Hui Xuan Lim & Chit Laa Poh. (2023) Development of Next Generation Vaccines against SARS-CoV-2 and Variants of Concern. Viruses 15:3, pages 624.
Crossref
Crossref
Justin C. Konje, Mariam Al Beloushi & Badreldeen Ahmed. (2023) Immunisation against COVID-19 in Pregnancy and of Women Planning Pregnancy. Viruses 15:3, pages 621.
Crossref
Crossref
Rehab A Mohammed, Rowaid S Yazbik, Lujain H Baajajah, Saud F Alharthy, Hassan Alsalahi, Mohammad A Mahjaa, Mahmoud M Barakat, Mayar I Badawy & Intessar Sultan. (2023) Side Effects Associated With Homologous and Heterologous COVID-19 Vaccines: A Cross-Sectional Study in Saudi Arabia. Cureus.
Crossref
Crossref
Yu Bai, Dong Liu, Qian He, Jianyang Liu, Qunying Mao & Zhenglun Liang. (2023) Research progress on circular RNA vaccines. Frontiers in Immunology 13.
Crossref
Crossref
Samira Hossaini Alhashemi, Fatemeh Ahmadi & Ali Dehshahri. (2023) Lessons learned from COVID-19 pandemic: Vaccine platform is a key player. Process Biochemistry 124, pages 269-279.
Crossref
Crossref
Ahmed I. Abulsoud, Hussein M. El-Husseiny, Ahmed A. El-Husseiny, Hesham A. El-Mahdy, Ahmed Ismail, Samy Y. Elkhawaga, Emad Gamil Khidr, Doaa Fathi, Eman A. Mady, Agnieszka Najda, Mohammad Algahtani, Abdulrahman Theyab, Khalaf F. Alsharif, Ashraf Albrakati, Roula Bayram, Mohamed M. Abdel-Daim & Ahmed S. Doghish. (2023) Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions. Biomedicine & Pharmacotherapy 157, pages 113977.
Crossref
Crossref
Bernard N. Kanoi, Michael Maina, Clement Likhovole, Francis M. Kobia & Jesse Gitaka. (2022) Malaria vaccine approaches leveraging technologies optimized in the COVID-19 era. Frontiers in Tropical Diseases 3.
Crossref
Crossref
Claudia Almendárez-Rodriguez, Karla I. Solis-Andrade, Dania O. Govea-Alonso, Mauricio Comas-Garcia & Sergio Rosales-Mendoza. (2022) Production and characterization of chimeric SARS-CoV-2 antigens based on the capsid protein of cowpea chlorotic mottle virus. International Journal of Biological Macromolecules 213, pages 1007-1017.
Crossref
Crossref
Yumiko Nomura, Kiyohito Noda, Yuusuke Oohashi, Shin Okuda, Kazushige Maki, Takashi Ogawa, Takashi Nakano, Nao Tsuchida, Ken J. Ishii, Kunihiko Hayashi, Tatsuo Iiyama, Hiroshi Onodera, Koji Ishii, Mayumi Shikano & Nobuhiko Okabe. (2022) Proposal for the revision of the guidelines for Non-clinical studies of vaccines for the prevention of infectious diseases in Japan. Vaccine 40:19, pages 2810-2818.
Crossref
Crossref
Becky Mingyao Ma, Anthony Raymond Tam, Kam Wa Chan, Maggie Kam Man Ma, Ivan Fan Ngai Hung, Desmond Yat Hin Yap & Tak Mao Chan. (2022) Immunogenicity and Safety of COVID-19 Vaccines in Patients Receiving Renal Replacement Therapy: A Systematic Review and Meta-Analysis. Frontiers in Medicine 9.
Crossref
Crossref
Jung Hun Ju, Naery Lee, Sun-hee Kim, Seokkee Chang, Misook Yang, Jihyun Shin, Eunjo Lee, Sunhwa Sung, Jung-Hwan Kim, Jin Tae Hong & Ho Jung Oh. (2022) Points to consider for COVID-19 vaccine quality control and national lot release in Republic of Korea: focus on a viral vector platform. Osong Public Health and Research Perspectives 13:1, pages 4-14.
Crossref
Crossref
Bulent Kantarcioglu, Omer Iqbal, Joseph Lewis, Charles A. Carter, Meharvan Singh, Fabio Lievano, Mark Ligocki, Walter Jeske, Cafer Adiguzel, Grigoris T. Gerotziafas & Jawed Fareed. (2022) An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations. Clinical and Applied Thrombosis/Hemostasis 28, pages 107602962110566.
Crossref
Crossref
Doo Ryeon Chung. (2021) Responses against infectious disease pandemics: a narrative review on COVID-19. Precision and Future Medicine 5:4, pages 175-183.
Crossref
Crossref
Daniela Calina, Antonio F. Hernández, Thomas Hartung, Alexey M. Egorov, Boris Nikolaevich Izotov, Taxiarchis Konstantinos Nikolouzakis, Aristidis Tsatsakis, Panayiotis G. Vlachoyiannopoulos & Anca Oana Docea. (2021) Challenges and Scientific Prospects of the Newest Generation of mRNA-Based Vaccines against SARS-CoV-2. Life 11:9, pages 907.
Crossref
Crossref